arrow
G

Guilin Tang

the university of texas-md anderson cancer center
H指数:50
被引数:8,897

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Fusion partner dependent immunophenotype, chromoanagenesis, and prognosis in MEF2D-rearranged B-lymphoblastic leukemia

融合伴侣依赖的免疫表型、染色体再生及预后在<em>MEF2D</em>重排的B淋巴母细胞白血病中的作用

2026-11-070
PRE
Daratumumab ± pomalidomide maintenance after salvage autologous transplantation in relapsed multiple myeloma: a phase 2 study

在复发多发性骨髓瘤中,自体移植后使用达鲁单抗±泊马利度胺进行维持治疗:一项2期研究

2026-09-260
OAAI
Acute Myeloid Leukemia With KMT2A Amplification: A TP53-Alteration-Enriched Subgroup Associated With Chromoanagenesis and Poor Prognosis

伴有KMT2A扩增的急性髓系白血病:<em>TP53</em>突变富集的亚组,与染色体重生及不良预后相关

2026-09-170
PRE
Carfilzomib, lenalidomide, and dexamethasone (KRd) versus bortezomib, lenalidomide, and dexamethasone (VRd) induction prior to autologous haematopoietic stem cell transplant/transplantation in newly diagnosed multiple myeloma

卡非佐米、来那度胺和地塞米松(KRd)与硼替佐米、来那度胺和地塞米松(VRd)在自体造血干细胞移植/移植前诱导治疗新诊断多发性骨髓瘤的比较

2026-08-200
PRE
D-VRD induction and autologous transplant in patients ≥70 years

D-VRD诱导和自体移植在≥70岁患者中的应用

2026-06-050
OAAI
Prognostic impact of ASXL1 mutations in acute myeloid leukemia treated with lower intensity therapy

低强度治疗下急性髓系白血病中ASXL1突变的预后影响

Cancer
IF5.1
2026-05-060
OA
Current and Future Utilization of Optical Genome Mapping Insights From the 2024 College of American Pathologists Supplemental Questionnaire

2024年美国病理学家学会补充问卷中光学基因组图谱的当前与未来应用

2026-05-010
PRE
Outcomes of therapy-related non-core binding factor acute myeloid leukemia with venetoclax-based therapies

与疗法相关的非核心结合因子急性髓系白血病的维奈克拉为基础的治疗结局

2026-02-120
OAAI
Results of delayed or salvage autologous hematopoietic stem cell transplantation for multiple myeloma

延迟或挽救性自体造血干细胞移植治疗多发性骨髓瘤的结果

2025-12-050
PRE
Comparative Analysis of Targeted RNA-Seq and Optical Genome Mapping for Detecting Gene Rearrangements in Acute Leukemia

靶向RNA测序与光学基因组图谱在急性白血病基因重排检测中的比较分析

2025-10-290
OAAI
A tour of leukemia progress in 2025, viewed through the MD Anderson leukemia research lens

2025年白血病研究进展回顾:通过MD Anderson白血病研究视角进行审视

Cancer
IF5.1
2025-10-230
OAAI